WORX - SCWorx Corp. Stock Analysis | Stock Taper
Logo
SCWorx Corp.

WORX

SCWorx Corp. NASDAQ
$1.11 4.72% (+0.05)

Market Cap $303463
52w High $13.05
52w Low $0.76
P/E -0.12
Volume 284.80K
Outstanding Shares 273.39K

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $768.9K $542.84K $-749.18K -97.44% $-0.71 $-614.03K
Q3-2025 $705.8K $390.78K $-1.31M -185.96% $-2.25 $2.29M
Q2-2025 $682.63K $473.94K $-1.91M -279.23% $-6.9 $-371.63K
Q1-2025 $720.3K $470.86K $-476.3K -66.13% $-3.75 $-334K
Q4-2024 $675.75K $538.77K $-195.29K -28.9% $-1.95 $-152.92K

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $1.64M $7.9M $743.6K $7.15M
Q3-2025 $684.29K $7.18M $1.18M $6M
Q2-2025 $340.21K $6.65M $1.2M $5.45M
Q1-2025 $1.07M $7.16M $1.56M $5.59M
Q4-2024 $106.65K $6.35M $1.86M $4.49M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $-749.18K $-129.08K $-30.64K $1.12M $960.14K $-139.7K
Q3-2025 $-1.31M $-358.08K $0 $702.17K $344.09K $-358.08K
Q2-2025 $-1.91M $-651.83K $0 $-80.37K $-732.21K $-651.83K
Q1-2025 $-476.3K $-404.62K $0 $1.37M $965.76K $-404.62K
Q4-2024 $-195.29K $-134.43K $0 $153.42K $18.99K $-134.43K

Revenue by Products

Product Q1-2018Q2-2018
Athlete Management
Athlete Management
$0 $0
Corporate Segment
Corporate Segment
$0 $0
Promotion Segment
Promotion Segment
$0 $0
Ticket Service Segment
Ticket Service Segment
$0 $0

5-Year Trend Analysis

A comprehensive look at SCWorx Corp.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Key positives include a specialized SaaS offering that targets a real and costly pain point for hospitals—data fragmentation and supply chain inefficiency. The company demonstrates a workable gross margin structure, strong short-term liquidity, low traditional debt, and a net cash position. Its product strategy, centered on a comprehensive, interoperable data platform with modular components, provides a clear narrative and potential for sticky customer relationships. These elements together give SCWorx a foundation for potential growth if it can execute commercially and operationally.

! Risks

The most important risks are financial: substantial operating and net losses, negative cash flow from operations, and reliance on external financing to grow or even maintain operations. Deeply negative retained earnings and an asset base dominated by goodwill and other intangibles highlight a history of losses and potential vulnerability to future write-downs. Competitive risks are also significant, given the presence of much larger healthcare IT players and the company’s small scale and limited brand recognition. If revenue growth does not accelerate or costs are not meaningfully reduced, the current model may prove difficult to sustain over time.

Outlook

Looking ahead, SCWorx’s outlook hinges on its ability to translate its specialized technology and data platform into a broader, more profitable customer base before financial flexibility tightens. The strong liquidity position buys some time, but ongoing cash burn and high financing costs create pressure to show operational improvement. In a favorable scenario, increased adoption, better cost control, and deeper partnerships could gradually move the company toward a self-sustaining model. In a less favorable scenario, continued losses and competitive headwinds could force strategic changes, restructurings, or additional capital raises under potentially less attractive terms. Overall, the future path remains uncertain and will be driven primarily by execution, customer traction, and cost discipline.